Jesse L Berry Selected Research

TFX

7/2021	Inter-eye genomic heterogeneity in bilateral retinoblastoma via aqueous humor liquid biopsy.
12/2020	Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes.
1/2020	Cell-Free DNA Tumor Fraction in the Aqueous Humor Is Associated With Therapeutic Response in Retinoblastoma Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jesse L Berry Research Topics

Disease

28	Retinoblastoma (Glioblastoma, Retinal) 03/2022 - 01/2011
25	Neoplasms (Cancer) 06/2022 - 06/2011
6	Melanoma (Melanoma, Malignant) 01/2020 - 11/2013
4	Cataract (Cataracts) 01/2019 - 09/2015
4	Cicatrix (Scar) 09/2018 - 12/2015
2	Uveal melanoma 06/2022 - 09/2021
2	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2019
2	Astigmatism 01/2021 - 09/2015
1	Glaucoma 01/2022
1	Orbital Cellulitis 01/2022
1	Hemorrhage 01/2022
1	Retinal Detachment (Retinal Detachments) 07/2021
1	Chromosomal Instability (Chromosome Stability) 07/2021
1	Refractive Errors (Refractive Error) 01/2021
1	Disease Progression 01/2020
1	Vitreous Detachment (Posterior Vitreous Detachment) 06/2019
1	Hyperplasia 09/2018
1	Gliosis 09/2018
1	Necrosis 12/2017
1	Toxic Optic Neuropathy 12/2017
1	Burns 12/2017
1	Atrophy 01/2017
1	Carcinogenesis 04/2016
1	Optic Nerve Diseases (Optic Neuropathy) 09/2015

Drug/Important Bio-Agent (IBA)

8	Retinaldehyde (Retinal)IBA 12/2020 - 04/2016
7	Melphalan (Alkeran)FDA LinkGeneric 12/2020 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 11/2017
5	Biomarkers (Surrogate Marker)IBA 06/2022 - 11/2018
5	Cell-Free Nucleic AcidsIBA 01/2021 - 11/2017
3	TFXIBA 07/2021 - 01/2020
1	Guanosine Diphosphate (GDP)IBA 03/2022
1	SolutionsIBA 01/2021
1	NucleotidesIBA 01/2021
1	Retinal Pigments (Pigments, Visual)IBA 09/2018
1	Topotecan (Hycamtin)FDA LinkGeneric 12/2017
1	Dihydrotachysterol (AT 10)IBA 12/2017
1	Methotrexate (Mexate)FDA LinkGeneric 12/2017
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2017
1	Verteporfin (Visudyne)FDA Link 12/2017
1	Nucleic AcidsIBA 11/2017
1	GadoliniumIBA 09/2017
1	ArgonIBA 12/2015
1	Iodine-125IBA 09/2015
1	IsotopesIBA 09/2015
1	RutheniumIBA 09/2015
1	IodineIBA 11/2013
1	Etoposide (VP 16)FDA LinkGeneric 04/2013
1	Vincristine (Oncovin)FDA LinkGeneric 04/2013
1	Carboplatin (JM8)FDA LinkGeneric 04/2013

Therapy/Procedure

11	Drug Therapy (Chemotherapy) 01/2022 - 01/2011
5	Therapeutics 01/2021 - 09/2018
4	Brachytherapy 09/2021 - 09/2015
3	Lasers (Laser) 12/2017 - 12/2015
3	Injections 12/2017 - 01/2017
2	Salvage Therapy 01/2022 - 11/2017
2	Radiotherapy 01/2019 - 04/2013
2	Laser Therapy (Surgery, Laser) 09/2018 - 09/2017
2	Semiconductor Lasers 12/2017 - 12/2015
1	Operative Surgical Procedures 09/2021
1	Eyeglasses (Spectacles) 01/2021
1	Complementary Therapies (Alternative Medicine) 01/2019
1	Preoperative Care 01/2019
1	Adjuvant Chemotherapy 01/2019
1	Intraocular Lenses (Intraocular Lens) 01/2019
1	Orbital Implants 12/2018
1	Intravitreal Injections 11/2018
1	Conservative Treatment 10/2018
1	Photochemotherapy (Photodynamic Therapy) 12/2017
1	Proton Therapy 12/2017
1	Induced Hyperthermia (Thermotherapy) 12/2017
1	Sutures (Suture) 09/2015
1	Microbubbles 06/2011
1	Aftercare (After-Treatment) 01/2011